This inventor holds 2 USPTO granted patents. Top assignees: The University of Texas System, University of Michigan. Active years: 2019-2021.
Location History:
- Austin, TX (US) (2019)
- Galveston, TX (US) (2021)
Company Filing History:
2 out of 5,627 
1 out of 3,519 
Years Active: 2019-2021
Title: Na Ye: Innovator in Medicinal Chemistry
Introduction
Na Ye is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for cancer treatment. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Na Ye's latest patents include groundbreaking research on EPAC antagonists. These embodiments are directed to a series of novel EPAC antagonists that are designed, synthesized, and evaluated to develop diversified analogues based on the scaffold of the previously identified high-throughput (HTS) hit ESI-09. Another notable patent involves substituted amides for treating and preventing cancer. This invention relates to novel small molecule compounds having a quinolin-8-yl-nicotinamide structure, which are useful in treating, ameliorating, or preventing various forms of cancer, including pancreatic cancer.
Career Highlights
Throughout her career, Na Ye has worked with esteemed institutions such as the University of Texas System and the University of Michigan. Her research has garnered attention for its potential impact on cancer therapies.
Collaborations
Na Ye has collaborated with notable colleagues, including Jia Zhou and Nouri Neamati, who have contributed to her research endeavors.
Conclusion
Na Ye's innovative work in medicinal chemistry and her dedication to developing new cancer treatments highlight her importance in the field. Her contributions are expected to have a lasting impact on therapeutic strategies for cancer patients.